The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Here's how much Ozempic and similar drugs have soared in popularity since 2018 )
Also on site :
- Men have hundreds more saved in ‘rainy day’ funds than women, research indicates
- Trump announces U.S.-China trade talks in London
- Sungrow Releases the Groundbreaking PowerTitan 3.0 Energy Storage System Platform